8.26
前日終値:
$8.16
開ける:
$8.17
24時間の取引高:
1.35M
Relative Volume:
0.83
時価総額:
$323.23M
収益:
$193.06M
当期純損益:
$-22.51M
株価収益率:
-12.91
EPS:
-0.64
ネットキャッシュフロー:
$10.63M
1週間 パフォーマンス:
+13.93%
1か月 パフォーマンス:
+58.85%
6か月 パフォーマンス:
+41.20%
1年 パフォーマンス:
-11.18%
Lifemd Inc Stock (LFMD) Company Profile
LFMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
LFMD
Lifemd Inc
|
8.26 | 323.23M | 193.06M | -22.51M | 10.63M | -0.64 |
![]()
VEEV
Veeva Systems Inc
|
237.05 | 38.54B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
59.19 | 11.13B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
61.37 | 9.87B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
90.40 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
40.01 | 7.04B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-10 | 開始されました | Lake Street | Buy |
2024-12-04 | 開始されました | Mizuho | Neutral |
2024-08-23 | 再開されました | B. Riley Securities | Buy |
2024-06-05 | 開始されました | KeyBanc Capital Markets | Overweight |
2023-11-30 | 開始されました | Craig Hallum | Buy |
2023-07-21 | 開始されました | Cantor Fitzgerald | Overweight |
2023-07-03 | 開始されました | H.C. Wainwright | Buy |
2022-03-10 | 開始されました | Colliers Securities | Buy |
2021-10-04 | 再開されました | B. Riley Securities | Buy |
すべてを表示
Lifemd Inc (LFMD) 最新ニュース
LifeMD Might Run Higher (NASDAQ:LFMD) - Seeking Alpha
LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st
LifeMD raises 2025 revenue guidance to $275M driven by telehealth growth - MSN
Trading (LFMD) With Integrated Risk Controls - news.stocktradersdaily.com
(LFMDP) Investment Report - news.stocktradersdaily.com
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 By Investing.com - Investing.com Nigeria
LifeMD’s Earnings Call: Positive Growth and Strategic Expansion - TipRanks
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 - Investing.com Australia
BTIG maintains Buy rating, $12 target on LifeMD shares By Investing.com - Investing.com Nigeria
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story - simplywall.st
LifeMD, Inc. (NASDAQ:LFMD) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG maintains Buy rating, $12 target on LifeMD shares - Investing.com
LifeMD (LFMD) Exceeds Q1 Expectations and Raises 2025 Outlook - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD earnings beat by $0.07, revenue topped estimates - Investing.com Canada
LifeMD (LFMD) Reports Strong Q1 2025 Performance and Raises Guid - GuruFocus
LifeMD Inc Reports Q1 2025 Earnings: EPS of $0.01 Beats Estimates, Revenue Surges to $65.7 Million - GuruFocus
LifeMD Inc reports results for the quarter ended March 31Earnings Summary - TradingView
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: LifeMD Q1 2025 earnings beat expectations, stock rises - Investing.com
LifeMD (LFMD) Boosts FY25 Revenue and EBITDA Forecasts | LFMD Stock News - GuruFocus
LifeMD (LFMD) Surpasses Revenue Expectations with Strong Q1 Performance | LFMD Stock News - GuruFocus
LifeMD, Inc. SEC 10-Q Report - TradingView
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance - GlobeNewswire
LifeMD Crushes Q1 Expectations: 70% Telehealth Surge and Historic Profit Milestone - Stock Titan
LifeMD (LFMD) Sees High Call Activity Ahead of Earnings | LFMD Stock News - GuruFocus
LifeMD, Inc. Reports Strong Q1 2025 Results - TipRanks
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expec - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Have LifeMD Insiders Been Selling Stock? - simplywall.st
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators - MSN
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD (LFMD) to Announce Q1 2025 Earnings and Host Conference C - GuruFocus
LifeMD (LFMD) Enhances Access to Wegovy with NovoCare Partnershi - GuruFocus
Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy - eMarketer
LifeMD expands access to weight management drug Wegovy - Investing.com
Why Hims & Hers Health and LifeMD Are Skyrocketing Today - Mitrade
Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy - MSN
LifeMD Stock Pops As Company Expands Weight-Loss Offerings With Wegovy - Benzinga
Wegovy to be sold on Hims, Ro and LifeMD for reduced price - Yahoo
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk’s Plan To Sell Wegovy Via Telehealth Operators By Stocktwits - Investing.com India
LifeMD and Hims & Hers Health shares surge on Novo Nordisk partnerships - Investing.com
LifeMD (LFMD) Expands Access to Wegovy with NovoCare Partnership - GuruFocus
LifeMD Expands Access to Weight-Loss Drug Wegovy; Shares Surge - marketscreener.com
LifeMD Shares Surge on Expanded Access to Wegovy - MarketWatch
LifeMD Announces Plans to Expand Affordable Access to Wegovy® fo - GuruFocus
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients - The Manila Times
LifeMD Makes Wegovy More Affordable: New $499 Monthly Program Includes Home Delivery - Stock Titan
LifeMD buys key assets from Optimal Human Health MD - MSN
LifeMD, Inc. (NASDAQ:LFMD) Receives $11.00 Average Price Target from Brokerages - Defense World
LifeMD to Report First Quarter 2025 Financial Results on May 6 - GlobeNewswire
Lifemd Inc (LFMD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):